INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 94 filers reported holding INFINITY PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 34.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $146,000 | -17.0% | 108,367 | -3.9% | 0.00% | – |
| Q3 2016 | $176,000 | +19.7% | 112,709 | +2.0% | 0.00% | – |
| Q2 2016 | $147,000 | -94.5% | 110,510 | -78.1% | 0.00% | -100.0% |
| Q1 2016 | $2,660,000 | -42.3% | 504,780 | -14.0% | 0.00% | -40.0% |
| Q4 2015 | $4,608,000 | -12.0% | 586,989 | -5.3% | 0.01% | -16.7% |
| Q3 2015 | $5,236,000 | -21.8% | 619,685 | +1.3% | 0.01% | -14.3% |
| Q2 2015 | $6,697,000 | -27.2% | 611,678 | -7.1% | 0.01% | -22.2% |
| Q1 2015 | $9,200,000 | -15.6% | 658,097 | +1.9% | 0.01% | -18.2% |
| Q4 2014 | $10,904,000 | +73.1% | 645,630 | +37.5% | 0.01% | +83.3% |
| Q3 2014 | $6,300,000 | -3.1% | 469,443 | -8.0% | 0.01% | 0.0% |
| Q2 2014 | $6,504,000 | +6.1% | 510,519 | -1.0% | 0.01% | 0.0% |
| Q1 2014 | $6,132,000 | -15.6% | 515,737 | -2.0% | 0.01% | -14.3% |
| Q4 2013 | $7,267,000 | -64.3% | 526,181 | -55.0% | 0.01% | -65.0% |
| Q3 2013 | $20,360,000 | -2.3% | 1,168,110 | -9.2% | 0.02% | -9.1% |
| Q2 2013 | $20,840,000 | – | 1,287,038 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 6,353,645 | $4,017,000 | 0.19% |
| Gratus Capital, LLC | 1,117,154 | $706,000 | 0.08% |
| Bleichroeder LP | 250,000 | $158,000 | 0.03% |
| Polar Capital Holdings Plc | 5,000,000 | $3,162,000 | 0.02% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 545,508 | $345,000 | 0.01% |
| Ergoteles LLC | 419,652 | $265,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 249,000 | $157,000 | 0.00% |
| Y-Intercept (Hong Kong) Ltd | 41,396 | $26,000 | 0.00% |
| Heritage Financial Services, LLC | 4,749 | $3,000 | 0.00% |
| Evercore Wealth Management, LLC | 143,138 | $91,000 | 0.00% |